Novo Nordisk May Have Found an Even Better Anti-Obesity Drug

Turns out Wegovy was just an amuse-bouche. Novo Nordisk, the Denmark-based maker of hit anti-obesity drug Wegovy (and its close diabetes treatment cousin Ozempic) has been trialing a successor to Wegovy called amycretin. On Thursday, it announced that in Phase I trials, the new drug had performed…#novonordisk #denmark #doubletrouble #amycretin #wegovy #danish #novonordisks #tesla #tiktok #specialized
Source: Reuters: Health - Category: Consumer Health News Source Type: news